Date post: | 04-Apr-2018 |
Category: |
Documents |
Upload: | zaigham-hammad |
View: | 228 times |
Download: | 0 times |
of 82
7/29/2019 complete General Pharmacology
1/82
7/29/2019 complete General Pharmacology
2/82
WHO defines drug as:
A substance, material or product used or intended tobe used to modify or explore the physiological
processes or pathological states for the benefit of therecipient.
e.g., Aspirin, cimetidine,
Loperamide, Morphine, etc.
1/15/2013 2
7/29/2019 complete General Pharmacology
3/82
Divisons/branches of pharmacology
1/15/2013 3
7/29/2019 complete General Pharmacology
4/82
Pharmacokinetics (ADME) Pharmacodynamics (Mechanism of action of drugs)
DRUG
Pharmacokinetic
concentration in plasma
concentration at the site of action
Pharmacodynamic
effect
1/15/2013 4
7/29/2019 complete General Pharmacology
5/82
Pharmacognosy
"the study of the physical, chemical,biochemical and
biological properties of drugs, drug substances or
potential drugs or drug substances of natural origin aswell as thesearch for new drugs from natural sources."
1/15/2013 5
7/29/2019 complete General Pharmacology
6/82
Pharmacy
It is a science of identification, source, selection,preparation, standardization, compounding and
dispensing of medicinal substances or drugs suitablesuitable for administration to the patient for thetreatment of different diseases. Now pharmacy dealswith rational use of medicines in patients.
1/15/2013 6
7/29/2019 complete General Pharmacology
7/82
Redstribution of Drugs
1/15/2013 7
7/29/2019 complete General Pharmacology
8/82
Clinical Pharmacology
It is the science which deals with the clinical
application of drugs especially on human beings.
1/15/2013 8
7/29/2019 complete General Pharmacology
9/82
Toxicology
Toxicology is the branch of pharmacology which
includes the study of adverse effects of drugs on the
body. It deals with the symptoms, mechanisms,treatment and detection of poisoning caused by
different chemical substances.
1/15/2013 9
7/29/2019 complete General Pharmacology
10/82
pharmacopoeias, formularies
1/15/2013 10
7/29/2019 complete General Pharmacology
11/82
Is an official book authorized by the respectivegovernments consisting of official standards for purity,strength, quality and analysis of drugs.
e.g., BP, USP/NF, European Pharmacopeia
1/15/2013 11
7/29/2019 complete General Pharmacology
12/82
At hospital level e.g, hospital formulary
At national level e., Orange book
1/15/2013 12
7/29/2019 complete General Pharmacology
13/82
Where to get the drug/ medicine information
Primary
Secondary
Tertiary
1/15/2013 13
7/29/2019 complete General Pharmacology
14/82
Active priciples of drugs
1/15/2013 14
7/29/2019 complete General Pharmacology
15/82
Doses of drugs
1/15/2013 15
7/29/2019 complete General Pharmacology
16/82
It is the amount of drug which will produce certainmeasurable biological response either at once or aftersometime when administered.
Or
Dose is the minimum amount of drug which producesdesired pharmacological effects.
1/15/2013 16
7/29/2019 complete General Pharmacology
17/82
Therapeutic Dose
Toxic Dose
Maximal Dose
Minial Dose Lethal Dose
Graded Dose
Fatal Dose
Booster Dose
1/15/2013 17
7/29/2019 complete General Pharmacology
18/82
Test dose
Ceiling Dose
Initial Loading Dose
Maintenance Dose Median Effective Dose
Median Lethal Dose
1/15/2013 18
7/29/2019 complete General Pharmacology
19/82
Dose calculation in adults and in children(Paediatrics)
1/15/2013 19
7/29/2019 complete General Pharmacology
20/82
Paediatric dose calculation formulas
1/15/2013 20
7/29/2019 complete General Pharmacology
21/82
1/15/2013 21
7/29/2019 complete General Pharmacology
22/82
1/15/2013 22
7/29/2019 complete General Pharmacology
23/82
Is the passage of drug through cell membrane
to reach its site of action
1/15/2013 23
7/29/2019 complete General Pharmacology
24/82
1. Simple diffusion = passive diffusion.
2. Active transport or carrier mediated transport e.g.,
vitamins, sugars, amino acids.
3. Facilitated diffusion .
4. Pinocytosis (Endocytosis) e.g., BaSO4
1/15/2013 24
7/29/2019 complete General Pharmacology
25/82
7/29/2019 complete General Pharmacology
26/82
26
7/29/2019 complete General Pharmacology
27/82
271/15/2013
Drug related
Lipid water solubility
Particle size
Degree of ionization
Physical forms
Chemical nature
Dosage forms Formulation
Concentration
Area of absorptivesurface
Vascularity pH
Presence of othersubstances
GI Motility Functional integrity
Diseases
Body related
7/29/2019 complete General Pharmacology
28/82
Definition:
bioavailability is a measurement of the rate and extent
to which a drug reaches the systemic circulation. It is
denoted by the letter f(or, if expressed in percent,by F).
7/29/2019 complete General Pharmacology
29/82
Physical properties of the drug ( Hydrophobicity,hydrophilicity,
Drug formulation
Fasted or fed condition of the patient Gastric emptying rate
Interaction with other food or drugs
Health of the GIT
Individual variation in metabolic differences
Disease state
1/15/2013 29
7/29/2019 complete General Pharmacology
30/82
Definition
The period of time required for the concentration or
amount of drug in the body to be reduced to
exactly one-half of a given concentration oramount. Denoted by t 1/2
For example, after intravenous administration, if
maximum concentration is 16 mg and the half life is 2
hours, after 2 hours 8 mg will be left, and so on.
e.g., Salbutamol is 1.6 hours,Morphine is 2 to 3 hours
1/15/2013 30
7/29/2019 complete General Pharmacology
31/82
The concentration of a drug or chemical in a bodyfluidusually plasmaat the time a steady state
has been achieved, and rates of drug administration
and drug elimination are equal.
1/15/2013 31
7/29/2019 complete General Pharmacology
32/82
Definition :the metabolism of orally administered drugs by
gastrointestinal and hepatic enzymes, resulting ina significant reduction of the amount of
unmetabolized drug reaching the systemiccirculation.
After a drug is swallowed, it is absorbed by the digestive system and enters the hepaticportal system. It is carried through the portal vein into the liver before it reaches therest of the body. The liver metabolizes many drugs, sometimes to such an extent thatonly a small amount of active drug emerges from the liver to the rest ofthe circulatory system. Thisfirst pass through the liver thus greatly reducesthe bioavailability of the drug. Alternative routes ofadministration like suppository, intravenous, intramuscular, inhalational aerosoland sublingual avoid the first-pass effect because they allow drugs to be absorbeddirectly into the systemic circulation.
1/15/2013 32
7/29/2019 complete General Pharmacology
33/82
the passage of drugs from blood to tissues.
1/15/2013 33
7/29/2019 complete General Pharmacology
34/82
BODY WATER COMPARTMENTS:50Kg 100Kg
(110 lb) (220 lb)
Total body water (60% body weight) = 0.6 L/Kg, 30 L 60 L
1. Extracellular (20% body weight) = 0.2L/Kg, 10 L 20 L
a). Plasma (4% body weight) = 0.04L/Kg, 2 L 4 L
b). Interstitial (16% body weight) = 0.16L/Kg, 8 L 16 L
2. Intracellular (40% body weight) = 0.4 L/Kg, 20 L 40 L
1/15/2013 34
7/29/2019 complete General Pharmacology
35/82
1/15/201335
7/29/2019 complete General Pharmacology
36/82
1/15/2013
36
7/29/2019 complete General Pharmacology
37/82
1/15/2013
37
7/29/2019 complete General Pharmacology
38/82
Body compartments where a drug can accumulate are
reservoirs. They have dynamic effects on drug
availability.
plasma proteins as reservoirs (bind drug)
cellular reservoirs
Adipose (lipophilic drugs)
Bone (crystal lattice)
Transcellular (ion trapping)
1/15/2013
38
7/29/2019 complete General Pharmacology
39/82
Passive movement of drugs across biological
membranes is influenced by protein binding. Binding
may occur with plasma proteins or with non-specific
tissue proteins in addition to the drugs receptors.
Only drug that is not bound to proteins (i.e., free
or unbound drug) can diffuse across membranes.
1/15/2013
39
7/29/2019 complete General Pharmacology
40/82
albuminbinds many acidic drugs
Globulin
bind hormones, vitamins etc., 1-acid glycoprotein
for basic drugs
The fraction of total drug in plasma that is bound isdetermined by its concentration, its binding affinity,and the number of binding sites.
1/15/2013
40
7/29/2019 complete General Pharmacology
41/82
Tetracycline antibiotics (and other divalent metal ion-chelating agents) and heavy metals may accumulate inbone. They are adsorbed onto the bone-crystal surfaceand eventually become incorporated into the crystal
lattice.
Bone then can become a reservoir for slow release oftoxic agents (e.g., lead, radium) into the blood.
1/15/2013
41
7/29/2019 complete General Pharmacology
42/82
Many lipid-soluble drugs are stored in fat. In obesity, fat
content may be as high as 50%, and in starvation it
may still be only as low as 10% of body weight.
70% of a thiopental dose may be found in fat 3 hr after
administration.
1/15/2013
42
7/29/2019 complete General Pharmacology
43/82
A highly lipid-soluble i.v. anesthetic. Blood flow to the
brain is high, so maximal brain concentrations brainare achieved in minutes and quickly decline. Plasma
levels drop as diffusion into other tissues (muscle)
occurs.
1/15/2013
43
7/29/2019 complete General Pharmacology
44/82
Substances that undergo enterohepatic circulation aremetabolized in the liver (usually by conjugation),excreted in the bile, and passed into the intestinallumen (where the intestinal bacteria break some of the
conjugated drug, releasing the unmetabolized drugagain) where they are reabsorbed across the intestinalmucosa (thus returns to systemic circulation again)and returned to the liver via the portal circulation
E.g. vit B12, Folic Acid,steroid hormone.
1/15/2013
44
7/29/2019 complete General Pharmacology
45/82
is the movement of drug from tissues and bloodto the external environment.
Renal excretion
Non renal excretion
1/15/2013
45
7/29/2019 complete General Pharmacology
46/82
Occure by 3 machanismsGlomerular filteration
Active secretion
ReabsorptionFor drugs with mol wt. < 300
1/15/2013
46
7/29/2019 complete General Pharmacology
47/82
Glomerular filteration rate
1/15/2013
47
7/29/2019 complete General Pharmacology
48/82
Is the volume of the fluid filtered from the renalglomerular capillaries in the Bowmanns capsule perunit time.
GFR is calculated by either creatinine excretion orInuline excretion
So GFR is the measurement of the working efficiency
of the kidneys.
1/15/2013
48
7/29/2019 complete General Pharmacology
49/82
Rate of bile secretion= 0.5-1ml/min For drugs with mol wt. > 500
1/15/2013
49
7/29/2019 complete General Pharmacology
50/82
The main organs responsible for drug excretion are thekidneys (renal excretion) and the liver (biliary excretion). Breath Urine Saliva Perspiration Feces Milk Bile (
Hair cannot be excreted before metabolism into more polar
compounds.
1/15/2013
50
7/29/2019 complete General Pharmacology
51/82
Is defined as the rate of drug elimination divided by theplasma concentration of the drug.
Drug clearance is concerned with the rate at which activeactive drug is removed from the body ; and for themost drugs at steady state, clearance remains constantso that drug input remains equal to drug output.
Increased clearance shorter the plasma half life of thedrug.
1/15/2013
51
7/29/2019 complete General Pharmacology
52/82
What the drug does to the body Def:
Mechanism of action or the physiological andbiochemical processes through which a drug producescertain effects or changes at the organ as well as at thecellular level.
1/15/2013
52
7/29/2019 complete General Pharmacology
53/82
Local action Systemic action
1/15/2013
53
7/29/2019 complete General Pharmacology
54/82
Do not impart any new function to any system, organor cell.
Only alter the pace of ongoing activity
Stimulation
Depression
Irritation
Cytotoxic action
Replacement
1/15/2013
54
7/29/2019 complete General Pharmacology
55/82
Primary effects ( required therapeutic effects)
Secondary effects (undesirable effects/side effects)
1/15/2013
55
7/29/2019 complete General Pharmacology
56/82
Action on specific receptors Action on specific enzymes
1/15/2013 56
7/29/2019 complete General Pharmacology
57/82
Receptors
Definitions
Classification
Ligands (Drugs)
Definitions
Classification
Ligand-Receptor interaction
Interaction and consequence
Receptor-mediated mechanism of action
7/29/2019 complete General Pharmacology
58/82
Drugs usually do not bind to these biomoleculesdirectly but act through specific macromolecules-
Receptors
Definition:
It is defined as a macromolecule or binding site locatedon cell surface or inside the effector cell that interactwith a drug and initiate the chain of events leading to
the drugs observed effects.
1/15/2013 58
7/29/2019 complete General Pharmacology
59/82
1/15/2013 59
7/29/2019 complete General Pharmacology
60/82
Reversible
ionic attraction, hydrogen
bonds
Van der waals forces.
Slowly reversible
/irreversible
high affinity covalent
binding, covalent binding
7/29/2019 complete General Pharmacology
61/82
Drugs or endogenous compounds binding to receptors are described asLigands.
Ligands are classified into 2 groups
Agonist: molecule that binds to receptor and produces similar response to that of
the endogenous ligand
Partial agonist agonist that produce partial effect
Full agonist
Antagonist: molecule that binds to a receptor, but does not cause a response
Competitive reversible or weak binding
Non-competitive non-reversible or strong binding
7/29/2019 complete General Pharmacology
62/82
Ligands(Agonist and Antagonist)
7/29/2019 complete General Pharmacology
63/82
Affinity: the attraction of the drug for the
receptor.
high affinity: low concentrations bind
low affinity: high concentrations bind
no affinity: does not bind
Efficacy: the intrinsic activity
Max. effect efficacy = 1
Min. effect efficacy = 0
7/29/2019 complete General Pharmacology
64/82
Intrinsic activity or efficacyIs defined as the capacity to stimulate for a given
receptor occupancy. It is determined by the molecularproperties of the drug.
The configurational pecularities that determine theintrinsic activity are different from those whichdetermine the effinity to the receptor.
1/15/2013 64
7/29/2019 complete General Pharmacology
65/82
Affinity Efficacy
Agonist yes high
Partial agonist yes low
Antagonist
Competitive low-medium no
Non-competitive high no
7/29/2019 complete General Pharmacology
66/82
Mechanism of of action:
anti-cholinesterase
Inhibits activity of acetyl-cholinesterase
ACh
AChE
acetate choline
Effects: increase Acetylcholine (ACh) levels in the
synapse.
Clinical use: treatment ofmyasthenia gravis
7/29/2019 complete General Pharmacology
67/82
1/15/2013 67
7/29/2019 complete General Pharmacology
68/82
Graded dose-response curveQuantal dose-response curve
1/15/2013 68
7/29/2019 complete General Pharmacology
69/82
It is defined as the quantitative curve in whichincreases doses of a drug produce varying changes ineffects.
Threshold dose
Ceiling effect
Graphical presentation of drug concentration onarithmatic scale (hyperbola shape) and when on log
scale (S shape).
1/15/2013 69
7/29/2019 complete General Pharmacology
70/82
1/15/2013 70
log dose
response
BA
7/29/2019 complete General Pharmacology
71/82
For effects like prevention of cardiac arrythmias, convulsions death. ALL OR NONE
A test animal pool is given a fixed dose and then the dose is noticed atwhich the effect and death s produced in 50% of animals
Percentage
individualResponse
ED 50 LD 50
1/15/2013 71
7/29/2019 complete General Pharmacology
72/82
age Body weight
Sex
Routes of administration
Time of administration
Effect of climate
Racial difference Dosage form of drugs
Age of drug
Absorption distribution and excretion of drugs
Pathologcal condtions
Hypersusceptibility Allergy
1/15/2013 72
7/29/2019 complete General Pharmacology
73/82
Drug-drug interactions Drug-food interactions
Drug lab interactions
1/15/2013 73
7/29/2019 complete General Pharmacology
74/82
When two or more drugs are given at the same time they mayexert their effect independently or they may interact i.e., onedrug may iinf luence the action of another drug. So
Is a situation in which one drug effects the action or efficacy ofanother drug when both drugs are administered together
As a result the final effect will be Synergism
a) Summation e.g., administration of two general anestheticsat a same time
b) Potentiation e.g., aspirin potentiate theanticoagulant effect of heparin and warfarin
Antagonistice.g., acetyle choline antaginise by atropine
1/15/2013 74
7/29/2019 complete General Pharmacology
75/82
In-vitro (outside the body before applicationto the patient)
In-vivo (within the body after intake by the
patient)
In vitro drug-drug interactions are alsocalled drug incompatiblities e.g., in thiopentone andsuxamethonium should not be filled in the same
syringe, in blood, amino acid, fat emulsions no drugshould be mixed. Heparin should not be mixed withdexrose solution etc.,
1/15/2013 75
7/29/2019 complete General Pharmacology
76/82
At Pharmacokinetic level At Pharmacodynamic level
1/15/2013 76
7/29/2019 complete General Pharmacology
77/82
What is pharmacokinetic?
ADME
1/15/2013 77
7/29/2019 complete General Pharmacology
78/82
Interactions effecting drug absorption : Due a reduction in total amount of drug absorbed is likely
to cause ineffective therapy
Drug effect the absorption of another drug by changing the
Gut motility, pH of gut motility, altering gut f lora byantimicrobials, and physicochemical interactions.
examples:
Antacids containing Ca or Al and tetracyclines,
Metoclopramide reduces absorption of cimetidine, liquidparaffin interferes with the absorption of vit D etc.,
1/15/2013 78
7/29/2019 complete General Pharmacology
79/82
Interactions due to changes in protein binding ofdrugs:
Drugs with high protein binding affinity displace thedrugs of low protein binding affinity drug and thus
increasing its concentration in the blood andincreasing efficacy . Drugs which have protein bindingaffinity of about 90% can do this e.g., indomethacine,sulphonamides displace anticoagulant warfarin
1/15/2013 79
7/29/2019 complete General Pharmacology
80/82
Interactions effecting drug metabolism: Enzyme induction many drugs induce the enzyme and
thus increase in the metabolism of the drug and reducingits plasma concentration and so its efficacy. For examplephenobarbitone accelerate the metabolism of oral anti-
coagulant (warfarin). Enzyme inhibition Some drugs inhibit the metabolism of another drug thus
increasing its plasma concentration and efficacy or toxicitydepending upon the concentration. For example isoniazid
potentiate action of phenytoin by inhibiting itsmetabolism.
1/15/2013 80
7/29/2019 complete General Pharmacology
81/82
Interaction effecting the renal excretion of thedrugs:
Drugs are eliminated through kidney by
glomerular filteration
Active tubular secretion
Compitition between drugs which share active transportmechanism in the proximal tubule
Example:Probenecid delays the excretion of many drugs e.g.,
penicillin, indomethacin etc,.
1/15/2013 81
7/29/2019 complete General Pharmacology
82/82
Due to similar or antagonistic pharmacological effectsor side effects.
Which may be due to competition at receptor site or occurebetween drugs acting on the physiological system
Potentiation: alcohol potentiate the effect of hypnotics andsedatives, aspirin potentiate effect of heparin
Summation: administration of two general anesthetics at asame time.
Antagonism: metoclopramide antagonises the effect ofatropine .